AniCell Fall 2016 Newsletter

IN THIS ISSUE

Canine & Equine Clinical Trials

MWI Distribution Agreement

BioScaff Line

2016 Conference Season

Clinical Trials for Dogs and Horses

Fall is upon us and AniCell’s products continue to increase in usage among veterinarians and accumulate efficacy and safety data for both horses and dogs. In order to obtain independent data and clinical science, we’ve partnered with the University of Chihuahua, Mexico, and began two research projects to study the efficacy of AniCell’s products in superficial wound healing and bone growth. These studies will provide the initial evidentiary science for the EquusCell and CanisCell brands. In October, AniCell will amass additional data with an Equine Wound study at North Carolina State University followed by a joint study in dogs. This is just the start of the data needed to support our various lines of products.

MWI Distribution Agreement

AniCell is pleased to announce the finalization of our distribution agreement with MWI/AmerisourceBergen. MWI has merged with AmerisourceBergen to become one of he world’s largest distributors of animal health products. AniCell is excited to be a part of their portfolio as one of the first regenerative “products” to be distributed by MWI. Now you can order both the EquusCell and CanisCell product line directly from MWI.

BioScaff Line

AniCell is excited to finally announce the release of our new BioScaff surgical line of products. These products are a customized derivative of our StemWrap line designed for indications such as colic surgery, colon resection, umbilical hernias as well as spays/neuters in dogs. Please check out these new products in the “Vet Only Access” section of our website.

2016 Conference Season

Conference Season is well under way and our team is looking forward to meeting you at the following conferences we will be attending: